Insights into Masimo's Upcoming Earnings
The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.
Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion
Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...
Benzinga.com8d
4 Analysts Assess Masimo: What You Need To Know
Masimo Corp is a global ... and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health ...
Nasdaq10d
Insights into Masimo's Upcoming Earnings
Masimo (NASDAQ ... and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products.
Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ETCompany ParticipantsEli Kammerman - VP of Business ...
Morningstar16d
Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion
Renowned Healthcare Facility Launches Advanced Wireless Monitoring Technology in the Emergency Department, Reducing Wait Times and Improving Patient Prioritization Masimo (NASDAQ: MASI) today ...
pharmaphorum7d
Novartis and Apple to scale up clinical trial collaboration
Most big pharma companies are now investing in digital technology to open up clinical trials to more patients via remote monitoring technology ... more efficient and patient and investigator ...